iFAST Diagnostics secures expanded UKCA Certification for Gram-negative isolates, adding to existing certification for Gram-negative bacteria blood cultures. iFAST has also secured UKCA Certification for Quantitative AST results from key drugs including Meropenem and Piperacillin-tazobactam.